Filing metadata

Accession number
0001104659-22-024867
Form type
Form 3
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
Feb 17, 2022
Reporting period
Feb 17, 2022
Description
Initial ownership

Explore SEC Filings Hub